Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

- Parkinson's Disease
- Completed

Study Title: A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Teva Identifier: TVP-1012/PM101

ClinicalTrials.gov Identifier: NCT00399477

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 30 Years and older

Trial Duration: 10/01/2006 - 07/01/2007

Phase: Phase 4

Study Type

Interventional